本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Corvus Pharmaceuticals, Inc.

10.65
+0.01000.09%
成交量:7.16萬
成交額:77.17萬
市值:8.98億
市盈率:-14.71
高:11.05
開:10.78
低:10.51
收:10.64
52周最高:26.95
52周最低:6.39
股本:8,435.31萬
流通股本:7,412.01萬
量比:0.96
換手率:0.10%
股息:- -
股息率:- -
每股收益(TTM):-0.7238
每股收益(LYR):-0.5320
淨資產收益率:-45.92%
總資產收益率:-27.83%
市淨率:4.31
市盈率(LYR):-20.02

資料載入中...

2026/11/10

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/11/05

重要事件披露

Form 8-K - Current report
2026/08/07

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/07

重要事件披露

Form 8-K - Current report
2026/07/28

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/22

重要事件披露

Form 8-K - Current report
2026/06/12

重要事件披露

Form 8-K - Current report
2026/05/15

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/05/14

重要事件披露

Form 8-K - Current report
2026/05/07

重要事件披露

Form 8-K - Current report
2026/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2026/04/27

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/04/24

重要事件披露

Form 8-K - Current report
2026/03/13

重要事件披露

Form 8-K - Current report
2026/03/12

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2026/03/12

重要事件披露

Form 8-K - Current report